首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Scedosporium prolificans Osteomyelitis in an Immunocompetent Child Treated with Voriconazole and Caspofungin as Well as Locally Applied Polyhexamethylene Biguanide
【2h】

Scedosporium prolificans Osteomyelitis in an Immunocompetent Child Treated with Voriconazole and Caspofungin as Well as Locally Applied Polyhexamethylene Biguanide

机译:用伏立康唑和卡泊芬净以及局部应用的聚六亚甲基双胍治疗的具有免疫功能的儿童多发性Sedosporium prolificans骨髓炎

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Scedosporium species are increasingly isolated from immunocompromised and immunocompetent patients. Unfortunately, Scedosporium infections are generally resistant to amphotericin B, and Scedosporium prolificans strains are particularly resistant to the antifungal agents now in use. We report here on an immunocompetent child with S. prolificans-associated osteomyelitis successfully treated with debridement, local irrigation with polyhexamethylene biguanide, and the systemic administration of voriconazole and caspofungin despite poor in vitro activity of voriconazole alone against the isolate. We also review the treatments and outcomes of 28 reported cases of osteomyelitis or septic arthritis caused by Scedosporium species in immunocompetent patients.
机译:壁孢菌属物种越来越多地从免疫功能低下和具有免疫能力的患者中分离出来。不幸的是,Scedosporium感染通常对两性霉素B具有抗性,而多产的Scedosporium prolificans菌株对目前正在使用的抗真菌剂具有特别的抗性。我们在这里报告了一个有免疫能力的小儿链球菌相关的骨髓炎的孩子,该患者通过清创术,聚六亚甲基双胍局部冲洗成功治疗,尽管单独使用伏立康唑对分离株的体外活性较差,但仍成功使用了伏立康唑和卡泊芬净。我们还回顾了免疫活性患者中28例由Scedosporium物种引起的骨髓炎或脓毒性关节炎的治疗和结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号